文献速递艾滋病与性传播感染

单倍体相合NK细胞联合白介素2或N-803治疗HIV感染的安全性与病毒学影响

Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
PubMed 文献 · J Infect Dis · 2024-01-01

一项在6例HIV感染者中开展的1期先导研究,单次输注单倍体相合相关供者NK细胞并联合IL-2或N-803,方案耐受良好,无意外不良事件,供者细胞在血液中可检测至8天、淋巴结和直肠中至28天,淋巴结中病毒RNA阳性细胞频率中度下降。

要点

  • 单次输注单倍体相合NK细胞联合IL-2或N-803耐受良好,无意外不良事件。
  • 供者细胞在血液中可检测至8天,在淋巴结和直肠中至28天。
  • 淋巴结中病毒RNA阳性细胞频率中度下降。

核心结论

  • 淋巴结中产HIV细胞中度减少,需进一步研究以确定健康NK细胞对HIV储存库的影响以及恢复NK细胞功能是否可作为HIV治愈策略的一部分。

研究设计与样本

  • 1期先导研究,纳入6例HIV感染者,单次输注单倍体相合相关供者NK细胞,联合IL-2或N-803(一种IL-15超激动剂)。

主要发现

  • 方案耐受良好,无意外不良事件。
  • 供者细胞在血液中可检测至8天,在淋巴结和直肠中可检测至28天。
  • 淋巴结中病毒RNA阳性细胞频率中度下降。

关键数值与推荐

  • 未预处理环磷酰胺或氟达拉滨以「腾出免疫空间」,理由为接受稳定抗逆转录病毒治疗的HIV感染者淋巴组织中仍存在T细胞耗竭。

局限性

  • 需进一步研究以确定健康NK细胞对HIV储存库的影响以及恢复NK细胞功能是否可作为HIV治愈策略的一部分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Natural killer (NK) cells are dysfunctional in chronic human immunodeficiency virus (HIV) infection as they are not able to clear virus. We hypothesized that an infusion of NK cells, supported by interleukin 2 (IL-2) or IL-15, could decrease virus-producing cells in the lymphatic tissues. METHODS: We conducted a phase 1 pilot study in 6 persons with HIV (PWH), where a single infusion of haploidentical related donor NK cells was given plus either IL-2 or N-803 (an IL-15 superagonist). RESULTS: The approach was well tolerated with no unexpected adverse events. We did not pretreat recipients with cyclophosphamide or fludarabine to "make immunologic space," reasoning that PWH on stable antiretroviral treatment remain T-cell depleted in lymphatic tissues. We found donor cells remained detectable in blood for up to 8 days (similar to what is seen in cancer pretreatment with lymphodepleting chemotherapy) and in the lymph nodes and rectum up to 28 days. There was a moderate decrease in the frequency of viral RNA-positive cells in lymph nodes. CONCLUSIONS: There was a moderate decrease in HIV-producing cells in lymph nodes. Further studies are warranted to determine the impact of healthy NK cells on HIV reservoirs and if restoring NK-cell function could be part of an HIV cure strategy. Clinical Trials Registration. NCT03346499 and NCT03899480.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Miller JS, Rhein J, Davis ZB, et al. Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection. J Infect Dis. 2024. PMID: 38207119. doi:10.1093/infdis/jiad578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。